Trial intelligence / Profile preview

VivaGel for Bacterial Vaginosis

NCT01577238Phase 3Completed

Sponsor
Starpharma
Start
Mar 2012
Primary completion
Jul 2012
Modality
Peptides, Polymer-based Nanoparticles
01

Overview

A Phase 3 trial of astodrimer in bacterial vaginosis (BV), sponsored by Starpharma. Started Mar 2012; status: completed.

02

Drugs

astodrimer
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on NCT01577238.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01577238.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call